Diagnostic players are focusing on preventive and wellness tests along with bundled test packages to grow their top lines. For many industry players, these tests now constitute around 10-20 per cent of their turnovers.
Arvind Lal, executive chairman of Dr Lal PathLabs said in the December quarter analysts call that, “India’s diagnostic sector is undergoing a rapid transformation. The increasing burden of non-communicable diseases, as well as new emerging and existing communicable diseases, increased adoption of evidence-based treatment and a growing emphasis on preventive healthcare diagnostics are expected to sustain the growth momentum.”
Dr Lal PathLabs already draws around 20